ÃâÒßѧÊÔÌâ
KHx2$*E_ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
GZO:lDdA 1. Fas(CD95)/FasL
:]:)c8!6 2. common chain of cytokine receptor
;PaU"z+Je~ 3 . TCR/CD3 complex
!4Aj#`) 4. negaive selection of thymocytes
LqYyIbsvf 5. artificial active immune
?OW!D? 6. anti-idiotypic
9mxg$P4 7. IgSF
4Q !A w 8. Integrin
U!uPf:p2 9. chemokine
2|x
!~e. 10. B7/CD28
X$KTsG* ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
\ Bj{.jL 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
frUs'j/bZ 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
2.WI".&y= 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
<O7!( 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
^?RH<z
:%&
E58 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
*EG
zFXa µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
7d
R?70Sz Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
O:#YLmbCN 1. B7/CD28
0Xb\w^ 2. Th1 subset
0)SRLHTY% 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
!`
%j#bv 4. antibody affinity maturation
6 eryf? 5. AP-1
q83^?0WD 6. single chain variable fragment£¨ScFv£©
t@R[:n;+ 7. NK cell receptor
<=
p>0L 8. Zinkernagel-Doherty phenomenon
N `:MF 9 9. Ig fold
_%R^8FjH* 10. CD40/CD40L
F oC
$X ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
-XXsob}/8 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
x?o#}:S 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
#WZat
?-N 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
3v\P6 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
xh:I]('R 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
1SztN3'q 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
7(]F+\A3 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
iS,l Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
rmzzbLTu £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
*VhEl7 Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
,93Uji[l 1.Co-stimulators (or co-stimulating molecules)
Fn.JtIu 2.NK-kB
8)bR\s 3.Immunoglobulin superfamily
1v|-+p42 4.antigen-presenting cell (APC)
Hc'Pp{| X 5.death domain
]UUa/ep- 6.CCR and CXCR
y:98}gW`n 7.Lectin (or mitogen)
K7`6G[RMb 8.Clusters of differentiation, CD)
-B#1+rUW 9.B7 family
D%]S>g5k 10.Cytotoxic T lymphocyte, CTL)
U4=l`{5on 11.IL-15 and IL-15 receptor (IL-15R)
KxK,en4)+ 12.MHC restriction
)9"^ D 13.Affinity-chromatography
,5v'hG 14.Cyctosprin A, CsA
KV$&qM. 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
SM8N*WdiU ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
nC p/.]Y* 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
=KHb0d |. 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
L0"|4= 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
2>9\o]ac4 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
pL1ABvBB ÃâÒßѧרҵ£º
5N
ZuaN 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
^g*Sy, A Ïû»¯ÄÚ¿Æ£º
r1< 'l 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
Zb=NcEPGy ѪҺ²¡Ñ§×¨Òµ£º
>
pb}@\;: 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
Hi={(Z5tC4 Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
UDr1t n (רҵ»ù´¡: ÃâÒßѧ)
V\zcv @ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
g)czJ=T2 1. ADCC(antibody dependent cell-mediated cytotoxicity)
dP_QkO 2. »·æß¾úËØ(cyclosporin)
jdG2u
p 3. KIR(killer cell inhibitory receptor)
S. `y%t.GP 4. HLDA(human leucocyte differentiation antigen)
8<
;. 5. Interleukin 18(IL-18)
Oh1U=V2~ 6. ÕûºÏËØ(integrin)
5
NYS@76o7 7. Fas/FasL
TNqL ')f 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
[Ix6ArY 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
Jn{)CZ 10. Th1/Th2
LmJjO:W}^y 11. »ùÒòÒßÃç(DNAÒßÃç)
U>*@VOgB 12. chemokines and chemokine receptor
dYISjk@ 13. ÃâÒßÄÍÊÜ
mh"PA p 14. ¹²´Ì¼¤·Ö×Ó
zqj|$YNC 15. ËÀÍö½á¹¹Óò(death domain)
w&H>`l06
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
7fypUQ:y 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
X$;x2mz nM 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
HR?T £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
GCYXDovh £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
&,{>b[ £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
EFDmNud`Q £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
?a,#p 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
!j7mY9x+ Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
JG^
GEJ ÎÊ´ðÌâ(ÿÌâ25·Ö)
,1 H|{ < 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
nL^7t7mp 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
<=|^\r
!}& 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
=k d-rIBc 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£